Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
Clinical trial NCT06634875 · RECRUITING
Trial details
- NCT number
- NCT06634875
- Sponsor
- Buzzard Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-30
- Primary completion
- 2026-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.